:: Library Catalog

Bearbmagovva

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Badhe, Pravin
Materiálatiipa:	Recurso digital
Giella:
Almmustuhtton:	Zenodo 2025
Liŋkkat:	https://doi.org/10.5281/zenodo.17898008
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid

In-Vitro Evaluation of ACTB Modulation: Implications for Biomarker Discovery, Drug Response Prediction, and Overcoming Chemoresistance in Breast Cancer Models
Dahkki: Badhe, Pravin
Almmustuhtton: (2025)

RNA-seq–Based Mechanistic Evaluation of Phytochemicals and Small Molecules in Experimental Cancer Models
Dahkki: Badhe, Pravin, et al.
Almmustuhtton: (2026)

Formulation Innovations Targeting ACTB Pathways in Breast Cancer: From Cytoskeletal Dysregulation to Precision Drug Delivery
Dahkki: Badhe, Ashwini
Almmustuhtton: (2025)

From Bench to Biomarkers: RNA-seq-Driven Discovery of Chemoprevention Biomarkers in Animal Models
Dahkki: Badhe, Ashwini, et al.
Almmustuhtton: (2026)

In Vitro Validation of Herbal Products: Insights from MTT, ELISA, and Mechanistic Assays
Dahkki: Badhe, Pravin
Almmustuhtton: (2025)

Pharma Marketing Management
Dahkki: Dr. Krishnananda Kamath K, Dr. Pravin Badhe, Tapan Kumar Mahato and Ashwini Badhe
Almmustuhtton: (2025)

Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis
Dahkki: Faith Mokobi Zablon, et al.
Almmustuhtton: (2024)

Design, Synthesis, Anticancer Evaluation, and EGFR‐Targeted Molecular Docking of Novel 4‐(benzylidenehydrazone)‐3‐nitropyridine Derivatives
Dahkki: Mahadevi Vitthal Kendre, et al.
Almmustuhtton: (2026)

Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR ‐Mutated Advanced Nonsmall‐Cell Lung Cancer
Dahkki: Chia‐Yu Kuo, et al.
Almmustuhtton: (2025)

Design and Synthesis of New Quinazoline Hybrid Molecules as EGFR Targeting Anti‐Breast Cancer Agents
Dahkki: Pandaga Saidulu, et al.
Almmustuhtton: (2026)

Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
Dahkki: Tvisha Devireddy, et al.
Almmustuhtton: (2025)

LegalSim: Multi-Agent Simulation of Legal Systems for Discovering Procedural Exploits
Dahkki: Badhe, Sanket
Almmustuhtton: (2025)

ScamAgents: How AI Agents Can Simulate Human-Level Scam Calls
Dahkki: Badhe, Sanket
Almmustuhtton: (2025)

Targeted Nanoprobes Enabled Precision Theranostics in Triple‐Negative Breast Cancer
Dahkki: Ke Ma, et al.
Almmustuhtton: (2025)

Identification and Characterization of Cytokine Genes in Breast Cancer for Predicting Clinical Outcomes
Dahkki: Zhifen Han, et al.
Almmustuhtton: (2025)

Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer
Dahkki: Rui Kitadai, et al.
Almmustuhtton: (2025)

Clinical Outcomes of Later‐Generation EGFR ‐ TKIs for Uncommon EGFR Mutations in NSCLC : A Multicenter Real‐World Study
Dahkki: Lisa Shigematsu, et al.
Almmustuhtton: (2025)

Breast Cancer: Targets and Therapy
Almmustuhtton: (2010)

Adaptive MRI With AI‐Guided Triage in Breast Cancer Screening: Clarifying the Terminology, Methodology, and Clinical Relevance
Dahkki: Deniz Esin Tekcan Sanli, et al.
Almmustuhtton: (2025)

Prompt-Level Distillation: A Non-Parametric Alternative to Model Fine-Tuning for Efficient Reasoning
Dahkki: Badhe, Sanket, et al.
Almmustuhtton: (2026)

Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple‐Negative Breast Cancer: A Comprehensive Analysis
Dahkki: Yanxia Zhang, et al.
Almmustuhtton: (2024)

Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer
Dahkki: Hong Liu, et al.
Almmustuhtton: (2024)

YIGSR Functionalized Hybrid Exosomes Spatially Target Dasatinib to Laminin Receptors for Precision Therapy in Breast Cancer
Dahkki: Pratiksha Tiwari, et al.
Almmustuhtton: (2025)

Emerging Nanozyme Strategies for Precision Breast Cancer Treatment
Dahkki: Jian Zang, et al.
Almmustuhtton: (2025)

Breast Cancer: Basic and Clinical Research
Almmustuhtton: (2008)

Overcoming EGFR‐Mediated Dendritic Cell Dysfunction to Enhance Anti‐tumor Immunity in EGFR‐Mutant NSCLC by Precisely Targeting CD73 With pH‐responsive Nanocarriers
Dahkki: Xiaoling Shang, et al.
Almmustuhtton: (2025)

Breast Cancer: Molecular Pathogenesis and Targeted Therapy
Dahkki: Md Abdus Samad, et al.
Almmustuhtton: (2025)

Learning a Clinically-Relevant Concept Bottleneck for Lesion Detection in Breast Ultrasound
Dahkki: Bunnell, Arianna, et al.
Almmustuhtton: (2024)

Relevance of the Human Microbiome in Breast Cancer: A Global Bibliometric and Visual Analysis
Dahkki: Faqeeha Javed, et al.
Almmustuhtton: (2024)

Better Outcomes for Ovarian Cancer Associated With the Detection of Anti‐EBV TCR CDR3s: Potential Relevance to Diffuse Large B‐Cell Lymphoma
Dahkki: Nandini Goel, et al.
Almmustuhtton: (2025)

The Silent Vote: Improving Zero-Shot LLM Reliability by Aggregating Semantic Neighborhoods
Dahkki: Badhe, Sanket, et al.
Almmustuhtton: (2026)

Long-Tail Knowledge in Large Language Models: Taxonomy, Mechanisms, Interventions and Implications
Dahkki: Badhe, Sanket, et al.
Almmustuhtton: (2026)

Taxonomy of the Retrieval System Framework: Pitfalls and Paradigms
Dahkki: Shah, Deep, et al.
Almmustuhtton: (2026)

AI ‐Driven Variant Annotation for Precision Oncology in Breast Cancer
Dahkki: Kriti Shukla, et al.
Almmustuhtton: (2025)

Nanomaterial‐Based Precision Medicine for Breast Cancer Diagnosis and Treatment
Dahkki: Tanaka Ndongwe, et al.
Almmustuhtton: (2025)

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer
Dahkki: Zhen Chen, et al.
Almmustuhtton: (2024)

Outcomes After Intratumoral Delivery of Immunotherapy in Breast Cancer
Dahkki: Camille C. Baumrucker, et al.
Almmustuhtton: (2026)

Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
Dahkki: Yerim Jin, et al.
Almmustuhtton: (2024)

Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment
Dahkki: Burak Kuzu, et al.
Almmustuhtton: (2025)

EGFR Signaling and Related Pathways: Potential Targets for CRISPR‐Mediated Gene Editing System in the Colorectal Cancer
Dahkki: Mobina Tabibian, et al.
Almmustuhtton: (2025)